Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269751 | 12626975 | 1 | I | 20160721 | 20160805 | 20160805 | EXP | AU-ECLAT PHARMACEUTICALS-2016ECL00016 | ECLAT | 0.00 | M | Y | 0.00000 | 20160805 | CN | US | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126269751 | 12626975 | 1 | PS | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | UNK | Y | U | 204736 | TABLET | |||||||
| 126269751 | 12626975 | 2 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126269751 | 12626975 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126269751 | 12626975 | Cardiac disorder | |
| 126269751 | 12626975 | Chest pain | |
| 126269751 | 12626975 | Cough | |
| 126269751 | 12626975 | Insomnia | |
| 126269751 | 12626975 | Muscular weakness | |
| 126269751 | 12626975 | Oropharyngeal pain | |
| 126269751 | 12626975 | Palpitations | |
| 126269751 | 12626975 | Pollakiuria | |
| 126269751 | 12626975 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126269751 | 12626975 | 1 | 201411 | 20160711 | 0 |